Company Overview
Snapshot
Founded in September 2017 by Yotam Zimmerman, Lightfective operates with 1–10 employees. The company has secured funding across one disclosed round and holds one patent. In June 2022, Lightfective expanded the international presence of its ReBorn device.
Business overview
Lightfective is a medical and aesthetic technology innovator focused on optimizing its patented Power LED technology for professional, constant-energy, light-based medical treatments. The company's core product, ReBorn, is a device for non-invasive fat reduction designed for professionals. It leverages advancements in LED technology to provide a safe and versatile light source for uniform, highly efficient energy-based treatments, specifically optimized for indications like non-invasive professional fat reduction. Lightfective operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Aesthetic Devices, serving healthcare providers and patients.
Strategic signal
In June 2022, Lightfective announced the continued international expansion of its ReBorn device. This signals growing market acceptance and strategic validation for its Power LED technology in the aesthetic and medical device sectors, indicating a focus on scaling its non-invasive fat reduction solution globally.
Company Intelligence Q&A
- When was Lightfective founded?
- Lightfective was founded in September 2017.
- Who is a co-founder of Lightfective?
- Yotam Zimmerman is a co-founder and CTO of Lightfective.
- What is Lightfective's primary product?
- Lightfective's primary product is ReBorn, a device for non-invasive fat reduction that utilizes Power LED technology.
- What was a key development for Lightfective in June 2022?
- In June 2022, Lightfective announced the continued international expansion of its ReBorn device, indicating a growing global presence for its technology.
- What type of technology does Lightfective specialize in?
- Lightfective specializes in optimizing patented Power LED technology for medical and aesthetic treatments, particularly for non-invasive fat reduction.